Heterologous HA DNA vaccine prime - inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses

被引:0
|
作者
Wang, S. [1 ]
Parker, C. [1 ]
Taaffe, J. [2 ]
Solorzano, A. [2 ]
Garcia-Sastre, A. [2 ]
Lu, S. [1 ]
机构
[1] Univ Massachusetts, Sch Med, Amherst, MA 01003 USA
[2] Mt Sinai Sch Med, New York, NY USA
关键词
Influenza A virus; DNA vaccine; Hemagglutinin; prime-boost;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页数:1
相关论文
共 26 条
  • [1] Heterologous HA DNA vaccine prime-inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses
    Wang, Shixia
    Parker, Chris
    Taaffe, Jessica
    Solorzano, Alicia
    Garcia-Sastre, Adolfo
    Lu, Shan
    VACCINE, 2008, 26 (29-30) : 3626 - 3633
  • [2] Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost
    Ledgerwood, Julie E.
    Hu, Zonghui
    Costner, Pamela
    Yamshchikov, Galina
    Enama, Mary E.
    Plummer, Sarah
    Hendel, Cynthia S.
    Holman, Lasonji
    Larkin, Brenda
    Gordon, Ingelise
    Bailer, Robert T.
    Poretz, Donald M.
    Sarwar, Uzma
    Kabadi, Alisha
    Koup, Richard
    Mascola, John R.
    Graham, Barney S.
    CONTEMPORARY CLINICAL TRIALS, 2015, 44 : 112 - 118
  • [3] Neutralizing Antibody Responses to Homologous and Heterologous H1 and H3 Influenza A Strains After Vaccination With Inactivated Trivalent Influenza Vaccine Vary With Age and Prior-year Vaccination
    Wang, Wei
    Chen, Qiong
    Ford-Siltz, Lauren A.
    Katzelnick, Leah C.
    Parra, Gabriel I.
    Song, Hyo Sook
    Vassell, Russell
    Weiss, Carol D.
    CLINICAL INFECTIOUS DISEASES, 2019, 68 (12) : 2067 - 2078
  • [4] Protective efficacy of a prime-boost protocol using H5-DNA plasmid as prime and inactivated H5N2 vaccine as the booster against the Egyptian avian influenza challenge virus
    Hussein, H. A.
    Ahmed, B. M.
    Aly, S. M.
    El-Deeb, A. H.
    El-Sanousi, A. A.
    Rohaim, M. A.
    Arafa, A. A.
    Gadalla, M. R.
    ACTA VIROLOGICA, 2016, 60 (03) : 307 - 315
  • [5] Comparison of protection against H5N1 influenza virus in mouse offspring provided by maternal vaccination with HA DNA and inactivated vaccine
    Zhang, Fenghua
    Fang, Fang
    Chang, Haiyan
    Peng, Bo
    Wu, Jian
    Chen, Jianjun
    Wang, Hanzhong
    Chen, Ze
    ARCHIVES OF VIROLOGY, 2013, 158 (06) : 1253 - 1265
  • [6] Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses
    Zhang, Lu
    Jia, Na
    Li, Jun
    Han, Yaping
    Cao, Wuchun
    Wang, Shixia
    Huang, Zuhu
    Lu, Shan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (07) : 1949 - 1958
  • [7] An evaluation of cytokine and cellular immune responses to heterologous prime-boost vaccination with influenza A/H7N7-A/H7N9 inactivated vaccine
    El Sahly, Hana M.
    Makedonas, George
    Corry, David
    Atmar, Robert L.
    Bellamy, Abbie
    Cross, Kaitlyn
    Keitel, Wendy A.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (12) : 3138 - 3145
  • [8] A Bivalent Heterologous DNA Virus-LikeParticle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses
    Jiang, Wenbo
    Wang, Shuangshuang
    Chen, Honglin
    Ren, Huanhuan
    Huang, Xun
    Wang, Guiqin
    Chen, Ze
    Chen, Ling
    Chen, Zhiwei
    Zhou, Paul
    JOURNAL OF VIROLOGY, 2017, 91 (09)
  • [9] Influenza bivalent vaccine comprising recombinant H3 hemagglutinin (HA) and H1 HA containing replaced H3 hemagglutinin transmembrane domain exhibited improved heterosubtypic protection immunity in mice
    Liu, Qiliang
    Xue, Chunyi
    Zheng, Jing
    Liu, Kang
    Wang, Yang
    Wei, Ying
    Liu, George Dacai
    Cao, Yongchang
    VACCINE, 2015, 33 (32) : 4035 - 4040
  • [10] Development of an mRNA vaccine against a panel of heterologous H1N1 seasonal influenza viruses using a consensus hemagglutinin sequence
    Ma, Ning
    Xia, Zhi-Wu
    Zhang, Zhe-Gang
    Nian, Xuan-Xuan
    Li, Xue-Dan
    Gong, Zheng
    Zhang, Guo-Mei
    Le, Yang
    Zhou, Rong
    Zhang, Jia-You
    Yang, Xiao-Ming
    EMERGING MICROBES & INFECTIONS, 2023, 12 (01)